News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Drew Moghanaki: SAFRON II Was a “SABR in Lieu of Systemic Therapy” Study for Lung Metastases
Drew Moghanaki/LinkedIn
Jun 7, 2025, 12:39

Drew Moghanaki: SAFRON II Was a “SABR in Lieu of Systemic Therapy” Study for Lung Metastases

Drew Moghanaki, Chief Medical Officer at Respirati and Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology at David Geffen School of Medicine at UCLA, shared a post on X:

“Prof. Shankar Siva reminds us that SAFRON II was a ‘SABR in lieu of systemic therapy’ study for patients with lung metastases at SABRCAN 2025.”

Drew Moghanaki: SAFRON II Was a "SABR in Lieu of Systemic Therapy" Study for Lung Metastases

More posts featuring Drew Moghanaki.

cancer Drew Moghanaki OncoDaily Oncology SABR SABRCAN 2025 SAFRON II Shankar Siva
Special Coverage
Science
Aug 15, 2025, 08:43
Francesco Massari: Our First Translational Research from ARON-1α
Voices
Aug 15, 2025, 08:32
Yüksel Ürün: AI in Drug Discovery
Dialogues
Aug 15, 2025, 08:28
ONCOFFEE: Vera Megdanova on Oncology, Family, and the Challenges of Practicing Medicine in Bulgaria
Blog Posts
Aug 15, 2025, 08:03
Carmen Monge-Montero: Sometimes the Bravest Thing You Can Do is Ask for Help
Science
Aug 15, 2025, 07:31
Bishoy Morris Faltas: Paired Plus-Minus Sequencing for Accurate Dual-Strand DNA Analysis
Stories
Aug 15, 2025, 06:47
Oya Gilbert's Story Highlights Urgent Need to Protect NIH Research Funding - AACR
Science
Aug 15, 2025, 06:42
Denis Panizza: How Tight Can SBRT Prostate Margins Go?
Science
Aug 15, 2025, 06:33
Immune Youth in Old Age: Mayo Clinic Uncovers the Double-Edged Sword - E. Shyam P. Reddy
Voices
Aug 15, 2025, 06:32
Where AI Meets the Future of Cancer Research - NFCR
Insight
Aug 15, 2025, 06:24
Harpreet Singh: New Era for ADCs in HER-2 + Metastatic Breast Cancer
Science
Aug 15, 2025, 06:18
Ramy Sedhom Shares Study on Inpatient Immunotherapy Outcomes
Science
Aug 15, 2025, 06:11
Miguel Bronchud: Can Use of Aprepitant During Chemotherapy Improve TNBC Outcomes?